Financhill
Sell
28

ALLO Quote, Financials, Valuation and Earnings

Last price:
$2.06
Seasonality move :
-5.1%
Day range:
$2.05 - $2.30
52-week range:
$1.78 - $5.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4,350.98x
P/B ratio:
0.93x
Volume:
3.1M
Avg. volume:
2.8M
1-year change:
-35.17%
Market cap:
$430.9M
Revenue:
$95K
EPS (TTM):
-$1.56

Earnings Data

Next earnings date for ALLO
Mar 14
2025
Most recent earnings per share
-$0.32
Beat by $0.00
(Nov 7/2024)
Consensus Estimate
-$0.32
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ALLO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $4.2K -- -- -$0.35 --
03/14/2025 Q4 $9.9K -- -- -$0.33 --
11/07/2024 Q3 $10K -- -$0.32 -$0.32 $0.00
08/07/2024 Q2 $893.9K -- -$0.35 -$0.35 -$0.00
05/13/2024 Q1 $10.4K $22K -$0.38 -$0.41 $0.03
03/14/2024 Q4 $22.4K $21K -$0.51 -$0.44 -$0.07
11/02/2023 Q3 -- -- -$0.37 -$0.52 $0.15
08/02/2023 Q2 -- -- -$0.53 -$0.59 $0.06
05/03/2023 Q1 -- -- -$0.68 -$0.62 -$0.06
02/28/2023 Q4 -- -- -$0.66 -$0.69 $0.03
11/02/2022 Q3 -- -- -$0.58 -$0.65 $0.07
08/09/2022 Q2 -- -- -$0.52 -$0.61 $0.09
05/04/2022 Q1 -- -- -$0.56 -$0.58 $0.02
02/23/2022 Q4 -- -- -$0.54 -$0.59 $0.05
11/04/2021 Q3 -- -- -$0.57 -$0.56 -$0.01
08/04/2021 Q2 -- -- -$0.53 -$0.54 $0.01
05/05/2021 Q1 -- -- -$0.25 -$0.40 $0.15
02/25/2021 Q4 -- -- -$0.53 -$0.55 $0.02
11/04/2020 Q3 -- -- -$0.52 -$0.55 $0.03
08/05/2020 Q2 -- -- -$0.53 -$0.54 $0.01
05/06/2020 Q1 -- -- -$0.50 -$0.58 $0.08
02/27/2020 Q4 -- -- -$0.58 -$0.68 $0.10
11/05/2019 Q3 -- -- -$0.50 -$0.54 $0.04
08/07/2019 Q2 -- -- -$0.41 -$0.44 $0.03
05/07/2019 Q1 -- -- -$0.32 -$0.44 $0.12
03/08/2019 Q4 -- -- -$0.37 -$0.25 -$0.12
11/21/2018 Q3 -- -- -$0.43 -$0.39 -$0.04

Allogene Therapeutics Earnings Questions

  • How Much did Allogene Therapeutics Generate in Revenue Last Quarter?

    Allogene Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Allogene Therapeutics Beat Earnings Last Quarter?

    Allogene Therapeutics announced earnings per share of -$0.32 which represents a beat of analyst forecast a -$0.32 per share.

  • Is Allogene Therapeutics Profitable?

    Allogene Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Allogene Therapeutics EPS Next Year?

    Allogene Therapeutics's earnings are forecast to decrease from -$2.09 per share to -$1.31 per share next year representing a decrease of -37.12%.

  • When is Allogene Therapeutics's Earnings Date?

    Allogene Therapeutics's next earnings date is March 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock